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Rationale, aims, and objectives: The true effect of laminar airflow (LAF) systems on
postoperative infection is disputed, partly due to uncertainty regarding the validity of
ventilation data in register studies. The aim of this study was to validate the informa-
tion on operating room (OR) ventilation reported by the orthopaedic surgeons to the
Norwegian Arthroplasty Register (NAR) after primary total hip arthroplasty (THA).
Method: Forty of the 62 public orthopaedic units performing primary THA in Nor-
way during the period 1987‐2015 were included. The hospitals' current and previous
ventilation systems were evaluated in cooperation with the hospitals head engineer.
We identified the type of ventilation system reported to the NAR and compared
the information with the factual ventilation in the specific ORs at the time of primary
THA.
Results: A total of 108 067 primary THAs were eligible for assessment. None of the
hospitals performed THA in true “greenhouse” (GH) ventilation. Fifty‐seven percent
of the primary THAs were performed in ORs with LAF and 43% in ORs with conven-
tional, turbulent ventilation (CV). Comparing the reported data with the validated
data, LAF was reported with a sensitivity of 86%, specificity of 89%, and positive pre-
dictive value (PPV) of 92%, with an accuracy of 88%. CV was reported with a sensi-
tivity of 89%, specificity of 87%, and PPV of 84%, with an accuracy of 88%. The total,
mean misreporting rate was 12%.
Conclusions: Surgeons were not fully aware of what kind of ventilation system
they operated in. This study indicates that conclusions based on ventilation data
reported on THA in the NAR should not be interpreted without considering the inac-
curacy of the data.
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1 | INTRODUCTION
Laminar airflow (LAF) systems have been used in operating rooms
(ORs) for ultraclean surgery since the late 1950s. The intention is to
reduce the incidence of postoperative infection by reducing the col-
ony forming unit (CFU) density in the air of the OR.1,2 The systems
work by sending linear and parallel streams of clean air with constant
velocity, directly on to the surgical field in order to, in theory, displace
and reduce the flow of less clean air to the surgical field. In contrast,
the conventional ventilation (CV) systems mostly use the dilution prin-
ciple and work by creating an overpressure using turbulent air.3 The
LAF systems are, however, rarely able to create true LAF3 and are
therefore more recently designated as unidirectional airflow (UDAF
or UDF) systems; but for simplicity, we will use the designation LAF
in the present paper.
The existing recommendations of LAF as a prophylactic measure of
postoperative infection, rest mainly on a randomized trial from a time
when standards on antibiotic prophylaxis were not fully established,
and was therefore not thoroughly adjusted for. The findings therefore
may not apply for the current situation.4 Subsequent observational
studies from the same decade that adjusted for antibiotic prophylaxis
demonstrated no influence of OR ventilation on the rate of postoper-
ative infection.5,6 Newer, registry‐based studies have suggested that
LAF actually increases the risk of postoperative infection.7-9 A recent
systematic review and meta‐analysis in the Lancet, based partly on
the above mentioned registry studies, concluded that LAF systems
should not be installed in new ORs.10 The conclusion is controversial
and may be premature.11,12 The Lancet review also includes a study
from the Norwegian Arthroplasty Register (NAR), not studying the
effect of LAF specifically, and which may be confounded by
misreporting.13
Before concluding rigorously in systematic reviews and meta‐anal-
yses, it is of fundamental importance that ventilation data are valid
and of good quality. The aim of the present study was to validate
the data on OR ventilation reported on primary total hip arthroplasty
(THA) cases to the NAR.
2 | MATERIAL AND METHODS
The NAR has registered individual data on primary THAs and THA
revisions since 1987. The surgeon fills in a form immediately after sur-
gery. The form contains information on patient identity, date of oper-
ation, the type of OR ventilation in addition to several other patient,
and surgery‐related factors. For each hospital, we used the NAR to
identify the type of OR ventilation reported for the primary THA, ie,
CV, LAF, or greenhouse (GH) ventilation (register form, Appendix A).
The period of inclusion was 1 September 1987 to 31 December 2015.
In order to validate the information on OR ventilation reported by
the surgeon, the hospitals' current and previous ventilation systems
were evaluated in direct contact and cooperation with the hospitals
NAR contact‐surgeon and the hospitals head engineer. Six hospitals
in a pilot study were visited in order to gain knowledge on the differ-
ent systems and method of data collection. The factual ventilation sys-
tems in the ORs were assessed using a detailed questionnaire
regarding the configuration and specifications of the ventilation sys-
tems (Appendix B). The questionnaire was used as guidance in the cor-
respondence with the engineers. Objective, technical specifications
from manuals were retrieved in cases of doubt. To be classified as a
LAF system, the ventilation set‐up had to be confirmed to have been
installed with a unidirectional diffuser array. These criteria are not suf-
ficient to verify true LAF conditions, but in this paper, the main issue
was whether the system was installed with a unidirectional diffuser
array or not, in order to do a direct comparison with the reported data.
To assess the correspondence between the reported and validated
ventilation data, we did a case‐to‐case comparison of the OR in which
each reported, primary THA was performed. The accuracy of
reporting, based on sensitivity and specificity for each ventilation
group, was then calculated.
If the ventilation system had been out of function, exchanged, or
updated, primary THAs reported from that year were excluded.
Sixty‐two public hospitals reported to the register in the period.
Twelve hospitals were excluded due to low numbers of primary THAs
or concurrent use of ORs with different ventilation systems. Fifty hos-
pitals were selected for inclusion. Five hospitals were excluded due to
missing contact with key personnel and five due to incomplete venti-
lation data (Figure 1). Forty hospitals had precise information on the
FIGURE 1 Flow chart showing hospital and total hip arthroplasty
(THA) selection
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OR ventilation, and these 40 hospitals reported 108 067 primary
THAs available for validation.
2.1 | Statistics
The sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV), accuracy of reported data, and misreporting
rate were calculated as presented in Figure 2. Statistical analyses were
performed using SPSS version 24 (SPSS Inc, 2004).
2.2 | Ethics
The registration of data and the study was performed confidentially on
patient consent and according to Norwegian and EU data protection
rules.
3 | RESULTS
A total of 108 067 primary THAs were included in the further analysis.
TheseTHAs constituted 66% of theTHAs reported to the NAR during
the study period; 57 % of the surgeries were performed in a room with
verified LAF, and 43% were performed in rooms with roof‐mounted,
verified CV. None of theTHAs were performed in true GH conditions.
Figure 3 gives a summarized comparison between the reported OR‐
ventilation and the factual OR ventilation. LAFwas reportedwith a sen-
sitivity of 86%, specificity of 89%, and Positive Predictive Value (PPV)
92%. This gave an accuracy of 88%. CV was reported with a sensitivity
of 89%, specificity of 87% and PPV of 84%, with an accuracy of 88%.
This gave a total misreporting rate of 12% for both LAF and CV.
4 | DISCUSSION
We found 12% misreporting of the OR ventilation used during primary
THA reported to the NAR.
FIGURE 2 Formulas for calculating measures. FP, false positive; FN, false negative; TN, true negative; TP, true positive
FIGURE 3 Comparison between surgeon‐reported ventilation data and validated ventilation data. CV, conventional ventilation; FN, false
negative; FP, false positive; GH, greenhouse ventilation; LAF, laminar airflow; NPV, negative predictive value; PPV, positive predictive value;
TN, true negative; TP, true positive
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Other registries have studied the preventive effect of LAF systems.
All of these studies are included in the latest meta‐analysis published
in The Lancet.10 Two studies based on data from The German KISS
(Krankenhaus [hospital] Infections Surveillance System) registry
showed an increased risk of severe surgical site infection (SSI) after
THA operated in LAF conditions compared with CV.7,9 They gathered
information on the different ventilation systems by using a question-
naire, where data were provided by the surgical departments. To
which degree these data were validated or from whom the data were
reported remains unclear. The New Zealand Joint Registry reported an
increased risk of revision due to deep infection after THA performed
in an LAF theatre.8 They validated the reported information by asking
the hospitals to confirm what kind of ventilation system they used. It
was not stated what kind of personnel answered these questions. Also
included in the latest meta‐analysis was a study from the NAR,13 using
invalidated, surgeon reported data on ventilation. In that NAR study,
OR ventilation was used only as an adjustment variable in the study
of time trends for revision due to infection. The relative risk of revision
due to infection was found to be 1.3 (95% CI, 1.1‐1.5) for LAF com-
pared with CV. The above mentioned studies contribute to the basis
for the new WHO‐guidelines,14 which recommend not to use LAF
for arthroplasty. Taking the results of our study into consideration, this
recommendation may be considered controversial, as the evidence is
of uncertain validity and quality.
4.1 | Strengths
The validated ventilation data, presented in the present study, is
based on a large, national registry, with 100% coverage and 97%
completeness in the reporting of primary THA.15-17 It offers an
opportunity to validate a majority of a national cohort from a long
period of time.
The validated data were based on the information retrieved from
the engineers responsible for the hospitals ventilation systems, and
this information was verified by the NAR contact surgeon. In addition,
in order to overcome possible reporting bias, we retrieved objective,
technical data from manuals and specifications on the hospitals venti-
lation in cases of doubt. Only indubitable information was included,
and hospitals with uncertain information were excluded.
4.2 | Potential weaknesses
Only 40 hospitals, representing 66% of the primary THAs reported to
the NAR, were eligible for validation of OR ventilation. Like the 40
included hospitals, the 22 excluded hospitals had THA activity
throughout the majority of the time period and a similar distribution
between local hospitals, regional hospitals, and elective centres. The
excluded hospitals also had similar completeness of reporting of pri-
mary THA and OR ventilation.16,17 Hence, we believe that the selec-
tion bias was minimal.
5 | CONCLUSION
Surgeons were not fully aware of what kind of ventilation system they
operated in when performing primary THA. This resulted in a 12%
misreporting rate for both CV and LAF systems. This indicates that
conclusions based on ventilation data in the NAR should not be
interpreted without considering the inaccuracy of the data as the sub-
sequent evaluations of the prophylactic effect of ventilation systems
against postoperative infection may turn out inaccurate.
ACKNOWLEDGEMENTS
All authors have approved the final article. H.L., E.L., and H.D. con-
ceived and planned the study. H.L. collected the data. H.L. and C.B.J.
performed the analyses. H.L. wrote the manuscript. All authors con-
tributed in interpretation of the analyses and critical revision of the
manuscript.
We would like to thank the NAR contact surgeons and engineers
at the hospitals for contributing to data collection. We also thank Nor-
wegian surgeons for persistently and thoroughly reporting primary
THAs to the NAR.
H.L. received a scholarship from the Norwegian Orthopedic Asso-
ciation in 2015 for his work on the subject.
CONFLICT OF INTEREST




1. Charnley J, Eftekhar N. Postoperative infection in total prosthetic
replacement arthroplasty of the hip‐joint. With special reference to
the bacterial content of the air of the operating room. Br J Surg.
1969;56(9):641‐649.
2. Alsved M, Civilis A, Ekolind P, et al. Temperature controlled airflow
ventilation in operating rooms compared with laminar airflow and tur-
bulent mixed airflow. J Hosp Infect. 2017. http://dx.doi.org/10.1016/j.
jhin.2017.10.013
3. Cao G, Nilssen AM, Cheng Z, Stenstad LI, Radtke A, Skogas JG. Laminar
airflow and mixing ventilation: which is better for operating room air-
flow distribution near an orthopedic surgical patient? Am J Infect
Control. 2019;47(7):737‐743.
4. Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D.
Effect of ultraclean air in operating rooms on deep sepsis in the joint
after total hip or knee replacement: a randomised study. Br Med J (Clin
Res Ed). 1982;285(6334):10‐14.
5. Marotte JH, Lord GA, Blanchard JP, et al. Infection rate in total hip
arthroplasty as a function of air cleanliness and antibiotic prophylaxis.
10‐year experience with 2,384 cementless Lord madreporic prosthe-
ses. J Arthroplasty. 1987;2(1):77‐82.
6. Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus pla-
cebo in total hip replacement. Report of a multicentre double‐blind
randomised trial. Lancet. 1981;1(8224):795‐796.
7. Brandt C, Hott U, Sohr D, Daschner F, Gastmeier P, Ruden H. Operat-
ing room ventilation with laminar airflow shows no protective effect on
4 LANGVATN ET AL.LANGVATN ET AL. 1025
the surgical site infection rate in orthopedic and abdominal surgery.
Ann Surg. 2008;248(5):695‐700.
8. Hooper GJ, Rothwell AG, Frampton C, Wyatt MC. Does the use of lam-
inar flow and space suits reduce early deep infection after total hip and
knee replacement?: the ten‐year results of the New Zealand Joint Reg-
istry. J Bone Joint Surg Br. 2011;93(1):85‐90.
9. Breier AC, Brandt C, Sohr D, Geffers C, Gastmeier P. Laminar airflow
ceiling size: no impact on infection rates following hip and knee pros-
thesis. Infect Control Hosp Epidemiol. 2011;32(11):1097‐1102.
10. Bischoff P, Kubilay NZ, Allegranzi B, Egger M, Gastmeier P. Effect of
laminar airflow ventilation on surgical site infections: a systematic
review and meta‐analysis. Lancet Infect Dis. 2017;17(5):553‐561.
11. Jutte PC, Traversari RA, Walenkamp GH. Laminar flow: the better
choice in orthopaedic implants. Lancet Infect Dis. 2017;17(7):695‐696.
12. Kumin M, Scarborough M. Laminar flow ventilation during surgery.
Lancet Infect Dis. 2017;17(6):581.
13. Dale H, Hallan G, Espehaug B, Havelin LI, Engesaeter LB. Increasing
risk of revision due to deep infection after hip arthroplasty. Acta
Orthop. 2009;80(6):639‐645.
14. Leaper DJ, Edmiston CE. World Health Organization: global guidelines
for the prevention of surgical site infection. J Hosp Infect.
2017;95(2):135‐136.
15. Arthursson AJ, Furnes O, Espehaug B, Havelin LI, Soreide JA. Valida-
tion of data in the Norwegian Arthroplasty Register and the
Norwegian Patient Register: 5,134 primary total hip arthroplasties
and revisions operated at a single hospital between 1987 and 2003.
Acta Orthop. 2005;76(6):823‐828.
16. Espehaug B, Furnes O, Havelin LI, Engesaeter LB, Vollset SE, Kindseth
O. Registration completeness in the Norwegian Arthroplasty Register.
Acta Orthop. 2006;77(1):49‐56.
17. The Norwegian Arthroplasty Register. Annual Report 2016. Retrieved
from: http://nrlweb.ihelse.net/eng/Rapporter/Report2016_english.
pdf. Accessed April 30, 2019.
How to cite this article: Langvatn H, Bartz‐Johannessen C,
Schrama JC, et al. Operating room ventilation—Validation of
reported data on 108 067 primary total hip arthroplasties in
the Norwegian Arthroplasty Register. J Eval Clin Pract.
2019;1–8. https://doi.org/10.1111/jep.13271
LANGVATN ET AL. 5
to cite this article: Langvatn H, Bartz‐Johannessen C,
JC, et al. Operating room ventilation—Validation of
data on 108 067 primary total hip arthroplasties in the
Norwegian Arthroplasty Regi er. J Eval Clin Pract. 2020;26:1022–
1 2 . https://doi.org/10.11 1/jep.13271
1026 LANGVATN ET AL.
APPENDIX A
6 LANGVATN ET AL.LANGVATN ET AL. 1027
APPENDIX B
LANGVATN ET AL. 71028 LANGVATN ET AL.
8 LANGVATN ET AL.LANGVATN ET AL. 1029
